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AbstrACt
Objective Stroke-survivors are at increased risk of future 
dementia. Assessment to identify those at high risk of 
developing a disease using predictive scores has been 
utilised in different areas of medicine. A number of risk 
assessment scores for dementia have been developed but 
none has been recommended for use clinically. The aim of 
this qualitative study was to assess the acceptability and 
feasibility of using a risk assessment tool to predict post-
stroke dementia.
Design Qualitative semi-structured interviews were 
conducted and analysed thematically. The patients and 
carers were offered interviews at around 6 (baseline) 
and 12 (follow-up) months post-stroke; clinicians were 
interviewed once.
setting The study was conducted in the North-East of 
England with stroke patients, family carers and healthcare 
professionals in primary and secondary care.
Participants Thirty-nine interviews were conducted (17 
clinicians and 15 stroke patients and their carers at baseline. 
Twelve stroke patients and their carers were interviewed at 
follow-up, some interviews were conducted in pairs).
results Barriers and facilitators to risk assessment 
were discussed. For the patients and carers the focus 
for facilitators were based on the outcomes of risk 
assessment for example assistance with preparation, 
diagnosis and for reassurance. For clinicians, facilitators 
were focused on the process that is, familiarity in 
primary care, resource availability in secondary care and 
collaborative care. For barriers, both groups focused on the 
outcome including for example, the anxiety generated from 
a potential diagnosis of dementia. For the patients/carers a 
further barrier included concerns about how it may affect 
their recovery. For clinicians there were concerns about 
limited interventions and how it would be different from 
standard care.
Conclusions Risk assessment for dementia post-stroke 
presents challenges given the ramifications of a potential 
diagnosis of dementia. Attention needs to be given to how 
information is communicated and strategies developed to 
support the patients and carers if risk assessment is used.
IntrODuCtIOn
There is currently no cure for dementia and 
it is estimated that the worldwide economic 
burden will rise to US$2 trillion by 2030.1 It 
has been suggested that the most powerful 
way to affect costs is by reducing the numbers 
of people who develop the illness. This may 
be facilitated by prediction of individual risk 
for the disease. Stroke is associated with an 
increased risk of dementia and cognitive 
impairment.2–4 A recent meta-analysis found 
that stroke is a strong independent risk factor 
for dementia.5 Stroke incidence and numbers 
of stroke-survivors are likely to increase due 
to simultaneous ageing populations and 
declining stroke mortality rates.6 Given that 
the incidence of dementia increases expo-
nentially with age,1 7 this will mean that post-
stroke dementia will also become increasingly 
prevalent. It will therefore be important 
to identify those at greatest risk of devel-
oping dementia following stroke in order to 
strengths and limitations of this study
 ► To the best of our knowledge this is the first quali-
tative study to examine critically the views of stroke 
patients and their family carers and clinicians about 
the acceptability and feasibility of a risk assessment 
approach to assist in earlier identification of post-
stroke dementia.
 ► Understanding stakeholder views on risk assess-
ment for dementia can help inform future strategies 
if risk assessment for dementia is used to assist 
with earlier diagnosis.
 ► The  patient participants came from one area of 
England who were able to attend hospital outpatient 
departments and so may not represent the views 
and experiences of those with more severe post-
stroke sequelae.
 ► Clinician participants came from one area of England 
and so may not represent the views of other service 
models in other regions of the UK.
 ► It is recognised that clinicians tended to be more fa-
miliar with the process of risk assessment and could 
elaborate further on the process involved.
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implement strategies to reduce risk. In general, strategies 
to reduce risk of dementia may include management of 
cardiovascular risk factors for example, smoking, diabetes 
as well as regular physical activity.8 
Risk prediction models for dementia to identify those at 
higher risk have been developed in whole populations9 10 
with some models specifically developed to predict cogni-
tive impairment and dementia in stroke populations.11–14 
These stroke-specific models predict dementia or cogni-
tive impairment over a relatively short time period (up to 
18 months14). In spite of the expanding research in this 
field, none of the dementia risk prediction tools have 
been clinically implemented. Further, no studies have 
assessed the feasibility or acceptability of implementing 
such a strategy in a stroke population. Although risk 
models are currently used in everyday clinical practice 
in other branches of medicine, in particular prevention 
of cardiovascular15 and cerebrovascular16 disease, it is 
unclear how clinicians would feel about using a similar 
strategy to predict dementia, particularly given the stigma 
surrounding the diagnosis and perceived limited inter-
ventions and increased awareness of cognitive difficulties 
that the patients and carers may have following stroke. 
Further, no studies have evaluated whether using risk 
assessment tools for dementia would be acceptable to 
stroke patients themselves.
This paper presents findings from a qualitative study 
conducted with the patients, carers and clinicians, which, 
in part, sought to critically examine their views about 
the acceptability and feasibility of using risk prediction 
models in post-stroke care to identify those at greatest risk 
of future dementia.
MethODs
Patient and public involvement
Patients and members of the public have been involved 
in the development of this study from the beginning of 
the proposal. A participant advisory group also oversees 
the work conducted and annual face-to-face meetings are 
held to inform them of the study findings. The partici-
pant advisory group consists of members from a stroke 
research patient and carer panel, an organisation aimed 
at capturing public views about research and from a 
dementia and neurodegeneration specialty patient and 
public involvement group. The same group reviewed 
the study materials to ensure suitability particularly for 
stroke-survivors and their family carers.
ethical approval
The study was conducted in the North East of England. 
Participants provided informed written consent prior to 
the interview.
Patient and carer sampling
Patients and carers were purposively sampled from stroke 
clinics that is, to ensure a mix of genders and a range 
carers were recruited. As part of routine clinical practice 
in UK stroke services, all stroke-survivors are invited 
to a specialist review at 6 months after the event which 
includes a general enquiry about memory concerns.17 If 
the patient reported any subjective memory concerns at 
the clinic and was over the age of 60 and were able to 
communicate effectively in English, the stroke specialist 
nurse would provide further study information. Family 
carers were also recruited if they were involved in the 
stroke-survivor’s care, for example, if they attended the 
clinic appointment with them. If potential participants 
were interested in taking part in the study, their details 
were passed onto the research team. On receipt of this 
information one researcher (EYHT) would make contact 
with the patient or carer. He would provide detailed 
information and an opportunity to ask questions about 
the study. Following their agreement to participate in the 
study, participants were asked to take part in an inter-
view immediately following their 6 month review and/or 
around 6 months later.
Clinician sampling
General practitioners (GPs) and secondary care clini-
cians (eg, stroke consultants, specialist nurses, physio-
therapists and occupational therapists) in the North East 
of England were contacted to participate in the study. 
Participants were given an opportunity to ask further 
questions. Clinicians were purposively sampled to ensure 
that a broad range of care professionals in both primary 
and secondary care were recruited.
Data collection
Interviews were conducted between April 2016 and 
August 2017 by one researcher (EYHT) who is a medical 
doctor. The topic guide was initially derived from relevant 
literature and expert clinical views within the research 
team. It was designed to be iterative to enable any topics, 
which had not been previously identified, to be pursued 
in subsequent interviews. Face-to-face semi-structured 
interviews were conducted with all but one participant 
(clinician) who had a telephone interview. The patient 
and family carer were interviewed individually or in pairs 
as requested by participants. Clinicians were interviewed 
individually. The part of the interviews focussing on risk 
assessment asked participants for their views on using risk 
assessment to help identify stroke-survivors who are most 
at risk of dementia in the future. They were also asked 
about the benefits and problems associated with the 
delivery of this assessment (eg, who and where it should 
be carried out), what variables could be used and how 
best to manage the outcome if individuals were found to 
be at high or low risk. At follow-up interviews, the patient 
and carer participants were asked to elaborate again on 
their views of a risk assessment process. Alongside this, 
the interviews also sought the views of stakeholders on the 
care experience of post-stroke individuals with memory 
problems from clinicians, patients and carers. The inter-
views also looked to understand the impact of post-stroke 
memory problems on the patients and carers. These views 
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on care experience from clinicians18 and the patients and 
carers19 have been reported elsewhere. The impact of 
post-stroke memory problems on the patients and carers 
will be reported separately. This paper reports the views 
of clinicians, patients and carers on risk assessment only. 
The process of risk assessment was described to partici-
pants. This was further emphasised with examples of 
published tools in order to highlight examples of variables 
used to ensure participant understanding of the process. 
Informed written consent was obtained from all partici-
pants prior to the interview commencing. All interviews 
were audio-recorded and then transcribed verbatim. To 
protect participant anonymity, unique identifiers were 
used throughout the process with identifiable personal 
data removed.
Data analysis
Interview data was analysed using thematic analysis20 
following the principles of the constant comparative 
method,21 an iterative approach which allows for issues 
raised in earlier interviews to be explored subsequently. 
Data analysis was both deductive and inductive in that we 
applied learning from previous research and compared 
with our own data as well as inductively deriving new 
themes from our data. We ceased data collection when 
the researcher felt that data saturation occurred. This was 
defined as being when a full understanding of the partic-
ipant’s perspective22 and also ‘informational redundancy’ 
had been reached.23 One researcher (EYHT) familiarised 
himself with the dataset and subsequently coded the tran-
scripts line-by-line. Initially, a small subset of transcripts 
were analysed to identify initial themes and these were 
discussed between CE and EYHT. Data collection and 
analysis was iterative and as interviews progressed, further 
analysis led to new themes emerging and refinement of 
existing themes and subthemes, which were subsequently 
grouped into broad categories to facilitate interpretation. 
The wider team (EYHT, CE, LR, BS and CP) discussed 
and agreed on the final categories which are presented 
below. For the patient and carer interviews, where 
follow-up interview data was also obtained, these were 
analysed as separate interviews to assess for any change in 
views over time. Data analysis continued after fieldwork 
had ceased. There was particular focus to understand 
what was important to the patients, carers and clinicians. 
Data analysis was facilitated by a data handing software 
package (NVivo V.11). The paper conforms to the stan-
dards for reporting qualitative research checklist24 (please 
see online supplementary table 1).
results
In total, 30 baseline (6 month) interviews were conducted, 
analysed and compared including: 15 patient and carer 
interviews (see table 1) and 17 primary and secondary 
care clinician interviews (see table 2). Two pairs of 
participants were interviewed together at baseline. Eight 
stroke-survivors and four carers agreed to a further 
follow-up interview 6 months later with nine interviews 
completed. Three pairs of participants were interviewed 
together at follow-up. One stroke-survivor declined 
further follow-up and another stroke-survivor and carer 
were not followed up due to medical reasons. The data 
from this study suggest that in terms of risk assessment 
facilitators and barriers exist to implementation. Whereas 
the patient facilitators focused on the outcome of the risk 
assessment, clinicians focused more on the process of risk 
Table 1 Interview participants (patients and carers)
Unique 
identifier 
(patients and 
carers) Role Gender Age
Follow-up 
interview 
conducted
P1 Stroke-survivor Female 80 No
P2 Stroke-survivor Female 76 Yes
P3 Stroke-survivor Female 72 Yes
P4 Stroke-survivor Male 75 Yes
P5 Stroke-survivor Male 80 Yes
P6 Stroke-survivor Male 74 Yes
P7 Stroke-survivor Female 73 Yes
P8 Stroke-survivor Female 82 Yes
P9 Stroke-survivor Male 84 No
P10 Stroke-survivor Male 79 Yes
C1 Carer of P1 (husband) Male 79 No
C2 Carer of P4 (wife) Female 79 Yes
C3 Carer of P5 (daughter) Female 57 Yes
C4 Carer of P6 (wife) Female 71 Yes
C5 Carer of P8 (daughter) Female 60 Yes
Table 2 Interview participants (clinicians)
Unique 
identifier 
(clinicians) Role Gender
SC1 Stroke consultant Female
SC2 Stroke specialist nurse Female
SC3 Stroke consultant Female
SC4 Stroke consultant Male
SC5 Stroke specialist nurse Female
SC6 Stroke physiotherapist (rehabilitation) Female
SC7 Stroke physiotherapist (acute care) Female
SC8 Stroke occupational therapist (acute care) Male
SC9 Stroke occupational therapist (rehabilitation) Female
PC1 General practitioner with specialist interest 
in dementia
Male
PC2 General practitioner Male
PC3 General practitioner Female
PC4 Nurse practitioner in primary care Female
PC5 General practitioner Female
PC6 Practice nurse Female
PC7 Nurse practitioner in primary care Female
PC8 General practitioner Female
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assessment for facilitators. Both groups discussed some 
potential barriers associated with risk assessment focus-
sing on the outcome.
Patient and carer views: facilitators to risk assessment 
focuses on the outcome of assessment
When stroke-survivors and carers discussed the concept of 
risk assessment, the overarching theme was that an assess-
ment outcome was what was important, irrespective of the 
process and clinicians involved. Participants focused on 
several areas of why the outcome was important to them.
For preparation
Some stroke-survivors were generally positive about 
receiving a risk assessment for dementia. One stroke-sur-
vivor acknowledged that a diagnosis was something that 
could enable individuals to prepare themselves both at 
baseline and subsequently at follow-up interview:
It’s the same as knowing and not knowing, if you 
know that something is approaching. Not everybody 
is the same with the problem. You might be able to 
deal with it in a different way or the person support-
ing you, the nurse or whoever, might be able to find 
a different way or a more positive way of managing it. 
(P6, male, stroke-survivor at follow-up interview)
Similarly, for carers, there was the emphasis on what 
could be done following the assessment. One carer 
emphasised the importance of looking after the whole 
person, and, how earlier recognition of a potential 
dementia diagnosis could ensure strategies were in place 
to help the individual:
But I think, if you look at the whole thing of this care 
of this person, if we knew earlier that you know the 
chances are that your memory is going to get bad and 
you are going to go into dementia or whatever, then 
we can start thinking, ‘Right, well let’s prop it up, 
let’s think of ways in helping your memory as it is, to 
maintain the level it is before you’ve got no choice, 
it’s going to get worse.’ You know, maintaining what 
you’ve got and different ways of maintaining it, I 
think that would help. (C5, female carer (daughter) 
of stroke-survivor)
For timely diagnosis
For some stroke-survivors it did not matter who was 
performing the risk assessment for dementia or where it 
was undertaken. What was important was that the diag-
nosis was reached at the right time:
I wouldn’t say it matters, as long as it’s diagnosed at 
the right time. (P5, male stroke-survivor)
When discussing who should perform the risk assess-
ment, carer participants felt that primary care and the 
community were regarded as being optimal because of 
the existing GP-patient relationship. This is because the 
GP has an overall view of the individual’s care:
I think if you’ve got a good relationship with your 
GP I think it should be that, it should be them. 
Yeah, because you know you trust them you build 
up a relationship with them so I think that probably, 
for me that would be the one. (C4, female carer of 
stroke-survivor)
For reassurance
When stroke-survivor participants were asked about a 
structured risk assessment process, a further participant 
reported that the outcome could also ensure some reas-
surance, either that their symptoms were not related to a 
dementia diagnosis or that a diagnosis of dementia would 
be accompanied by support:
I think it’s reassurance a lot of reassurance with peo-
ple. You have to give them that to tell them, that ‘We 
are there with you. We’re going to be helping you.’ 
And that’s you know, I think that’s a good thing. (P2, 
female stroke-survivor)
Patient and carer views: barriers to risk assessment focuses 
on the outcome of assessment
Anxiety around a potential diagnosis of dementia
Some carers commented on how the outcome from risk 
assessment could generate worry and anxiety because of 
the potential diagnosis of dementia:
To be honest, I don’t know if it would help somebody 
saying, ‘You’re like this, you’re upset because you’re 
like this now, but we actually think you’re going to get 
much worse.’ Do you know what I mean? (C3, female 
carer (daughter) of stroke-survivor)
This person’s opinion did not change when she was 
followed up 6 months later. The participant’s focus was 
again on worrying about what could develop and how 
not knowing about one’s risk would actually be more 
preferable:
If you could find out and then say, ‘Right, we’ve got 
this medication, or something, that can help you,’ 
maybe. But if they’re just going to tell you, and then 
you’ve got this hanging over your head, and you’re 
thinking, ‘When is it going to start?’ and then you’d 
be thinking you’d forget something and you’d think, 
‘Oh, that’s it, it’s coming’, which it would be quite 
normal if you hadn’t had that diagnosis, you’d think, 
‘Well I just forgot something, everybody does that. 
(C3, female carer (daughter) of stroke-survivor at fol-
low-up interview)
However, one carer felt that despite the worry a poten-
tial diagnosis may generate, the benefit of this would be 
to find strategies to maintain cognitive function:
I think if you had earlier diagnosis, then you would be 
sort of prepared before things got difficult to handle, 
or before problems arise, that would be a very good 
thing. The disadvantages as you say, alarming the 
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carers or the patients themselves, ‘I’m going to lose 
my mind.’ Because, particularly in the older genera-
tion, that’s a big worry to them. It is a big worry, it’s a 
big worry to all of us, but to older people particularly. 
(C5, female carer (daughter) of stroke-survivor)
Concerns about how it may affect their recovery
Not all stroke-survivors were as keen to engage in risk 
assessment, as there was emphasis on how this may affect 
them psychologically particularly when their physical 
deficits had recovered enough to allow them to return to 
a more usual routine. Therefore, although diagnosis was 
felt to be important, whether an individual would like to 
know was also dependent on their subsequent post-stroke 
recovery:
That’s difficult you know because I mean if you have 
an early diagnosis you know and say, well ‘It’s going to 
happen’ you know but at the moment now I seem to 
be progressing through, I’m driving now, you know 
I’m going back to meetings and whatever. I wonder 
whether an early diagnosis would restrict that. (P4, 
male stroke-survivor)
This was particularly evident when the patients were 
followed up 6 months later. One participant had actually 
changed her view over time. Although she had initially felt 
positive about the process, she then changed her mind 
when questioned on the same process at her follow-up 
interview:
I think my thinking has gone the other way for know-
ing about that. I think it’s sad. I think it’s a sad thing. I 
really do, I think it’s really sad that for people to know 
that they’re going to be at high risk, it’s a sad thing 
for it to happen to people, and I don’t think I’d want 
to be one of the sad people. I think I’d just want to be, 
potter along and that’s it. (P2, female, stroke-survivor 
at follow-up interview)
At follow-up interviews participants also felt that risk 
assessment should be an individual choice because of the 
ramifications of the assessment outcome that is, a poten-
tial diagnosis of dementia. Although clinicians may deem 
it to be helpful, the choice to undergo risk assessment 
needs to be a weighed up, which should negate any calls 
for it to be made a universally applied process:
I think, medically speaking, yes. On the other hand, 
does it give people things to worry about that they 
wouldn’t have worried about if you hadn’t done the 
tests? So, I think it depends really on your personal 
point of view. Do you want to be, you see I would look 
on the test as saying, well you’re at a low, you’ve got a 
low risk so that’s great but then if it turned out you’d 
got a high risk are you going to be more worried and 
less happy than you were before. It’s hard to really 
balance it, isn’t it? (P3, female, stroke-survivor at fol-
low-up interview)
Clinician views: facilitators to risk assessment focusses on 
the process
Clinicians discussed facilitators to risk assessment in terms 
of how the process may affect the individual and also how 
the process could be implemented in the future.
When discussing how to implement this process, both 
primary and secondary care specialists discussed the 
advantages associated with hosting this process within 
their own individual teams.
Process familiarity in primary care
For primary care, it was about the fact that risk assessment 
was already a familiar process but that it needed to be 
individualised:
I think it’s a good tool. We’re quite good at using 
tools, aren’t we, but there’s always going to be excep-
tions to the rules and you’ve got to individualise what 
you do with it … But sometimes using a score or a 
tool is a way into a service. (PC4, nurse practitioner 
in primary care)
It was also recognised by one GP that although there 
is familiarity with risk assessment in primary care, there 
needs to be caution that the system is not overwhelmed 
with such tools:
I do quite like risk profiling. I think we went a lit-
tle bit crazy with the risk profiling. And there feels to 
be a lot of competing risk profiling tools, that we’re 
getting a little bit inundated with at the moment … 
So I think anything like this, I love, if it can be incor-
porated and brought on to an individual and needs 
level - so you can think about caring, identifying risk 
and needs for an individual - would feel great for me. 
(PC2, general practitioner)
Secondary care provides specialist input
Stroke care clinicians discussed the facilitators of risk 
assessment within a specialist setting. This was based on 
the fact that they felt a responsibility to ensure that post-
stroke sequelae are followed up in their specialist services 
due to the multidisciplinary element of their standard 
practice and easier access to services. This was particularly 
important to ensure information could also be given to 
the patients at a time when they may need it the most:
I think the 6 month review tends to be a period of 
time when the patient’s acute side, acute phase of 
their care has kind of been established, and this is 
probably the time when they start to recognise prob-
lems. And I think it should be within a stroke MDT 
(multidisciplinary team), not so much focused on by 
GP’s, as such. (SC2, stroke specialist nurse)
Well, you need the right support. You need people 
that actually understand stroke. So I think it would 
have to be delivered by stroke healthcare profes-
sionals. And I think you get so much information 
when you’re initially an inpatient, I think maybe 
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that’s not the best place to do it … Yeah, it’s a big 
thing to be told that you might develop dementia 
in a few years’ time, so you need psychologists kind 
of available for if someone needs counselling as a 
result of that finding. I think it’s tricky. (SC6, stroke 
physiotherapist)
Collaborative care
Primary care clinicians commented that there may be 
a place for both primary and secondary care to work 
together in identifying those at risk.
I think primary care would be a completely reason-
able place to do that. I guess it’s a conversation that 
could start at diagnosis, at discharge from hospital, 
like actually, we know that people who have had a 
stroke are at higher risk of having dementia, these 
are the things to be aware of, and you know to start 
that discussion (PC8, general practitioner)
Primary and secondary care clinicians felt that such a 
shared care pathway needed to be formalised to reduce 
the risk of individuals falling into gaps in care:
… even if it was picked up in secondary care it’s still 
going to be primary care where most of the manage-
ment is occurring. So I think it being identified at 
the 6 month follow-up, but then there being a for-
mal sort of mechanism, in which primary care pick 
it up and process it, would be fine. (PC3, general 
practitioner)
I don’t mind where work is done, provided that it is 
done in a structured and standardised way. If that 
be, if that can be in primary care that is really good, 
because that is the long-term follow-up, long-term 
support, integrating the community … just as long 
as it can be delivered in a systematic way, and people 
don’t fall through gaps or get inconsistent care. (SC3, 
stroke consultant)
Further, the process of communication between 
primary and secondary care could also be used in the 
diagnostic process. It was felt that repeated assessments 
could help facilitate diagnosis by identifying trends in 
symptoms:
You can measure a trend, can’t you, if you’re using 
something and measuring something, you can look 
at a trend. So if its, depends on the type of tool, I 
guess. But if you did it at you know at the 6 months 
review date and then we did it subsequently a year 
later in primary care, you would see any changes or 
decline or improvement. So it’s a way of, it’s a way 
of monitoring a trend on how they’re doing, I guess. 
So I don’t, I don’t see any reason why it couldn’t be 
done in both and used across both. I don’t think we 
use enough across both. (PC4, nurse practitioner in 
primary care)
Clinician views: barriers to risk assessment focusses on the 
outcome
Limited interventions available
Similar to the perspectives of carers, clinicians recognised 
the anxiety that a risk assessment process might generate 
and felt that it should be a personal choice to undertake an 
assessment because of the perceived lack of intervention:
Yeah, I think I would, I would have degree of anxiety, 
especially given that the measures that we’re putting 
in place are … that we could put in place are largely 
supportive rather than preventative … I would be less 
confident that I could be giving my patient advice to 
say, Well, if we do this, and we do this, and if we do 
this and you do that then that might move you into an 
even smaller risk group. (PC3, general practitioner)
Outside research trials, I’m not convinced that there 
is a definitive value in doing that yet. You know if we 
get really overwhelming evidence that it’s amenable 
to intervention so you know there’s all the theory 
about blood pressure, and statins, and all the rest of 
that, but my reading of the evidence on all of that at 
the moment is that the jury is out whether it makes 
a difference to cognitive function. So yeah, I’m not 
convinced that identifying risk, unless you’ve got a 
something you can do about it, is actually sensible. 
(SC4, stroke consultant)
Anxiety around a potential diagnosis of dementia
In recognising the anxiety that this process may generate, 
one clinician also commented on the fact that the patients 
may not be willing to engage in conversation over the 
subject of dementia and care should be taken when 
discussing a potential diagnosis of dementia.
I think it’s good if we tell them that we’re looking 
through and saying, ‘Look, you know there could be 
a problem here.’ But for every single patient, again, 
because it’s quite a still a – not a taboo subject – but 
it’s still not something that people want to talk about 
… I don’t know whether it would be used on every 
single ‘per’, you know what I mean, like, everybody. 
(SC5, stroke specialist nurse)
No change from standard practice
The majority of clinical participants wanted to know, 
not only what the outcome of the risk assessment would 
be, but also the resulting care the patient would receive. 
As part of current routine clinical care, all stroke-survi-
vors are offered annual reviews in order to ensure their 
vascular risk factors for example, blood pressure and 
cholesterol are well controlled. In terms of reducing risk, 
one primary care physician expressed concerns as to 
what the benefit would be to the individual if risk factor 
modification was already in place anyway, particularly 
with regards to the emotive side of a potential dementia 
diagnosis. A secondary care specialist questioned the 
value when there was seemingly limited interventions that 
 o
n
 9 April 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025586 on 27 March 2019. Downloaded from 
7Tang E, et al. BMJ Open 2019;9:e025586. doi:10.1136/bmjopen-2018-025586
Open access
could be implemented besides managing their cardiovas-
cular risk:
I guess you’ve got to be very clear about what it is that 
you’re going to be doing differently for them. So I 
can see the value if you use a tool for kind of primary 
prevention, then you’re kind of selecting a group of 
patients out to do something particular with, but I 
just wonder what would be different about what you 
do with a risk assessment tool for people who have 
already had a stroke, when really you know already 
that it is all about managing their cardiovascular risk 
so I’m not sure that you would be doing anything dif-
ferent for them. (PC8, general practitioner)
Many people will not know of the association between 
dementia and stroke and many people would not 
want to know if they were at risk of dementia and 
again, if you’re identifying somebody at risk of a 
condition that you can’t do anything about, what’s 
the right stage to, to do that? However, many of the 
things you need to do in terms of people being at 
risk of dementia are the same of the general cardio-
vascular. So, I’m not sure that there is anything addi-
tional that needs to be done about reducing people’s 
risk for dementia over and above general cardiovas-
cular risk. (SC3, stroke consultant)
DIsCussIOn
Main findings
This is the first study to explore key stakeholders’ - 
stroke-survivors, family carers and primary and secondary 
care clinicians - views on the use of a risk assessment 
process to predict future dementia in stroke-survivors. It 
is clear that some of the participants interviewed believed 
that risk assessment could be of clinical use, but raised 
concerns about it being mandatory. Clinicians high-
lighted both the benefits of collaborative and individual 
(ie, primary or secondary) care if dementia risk assess-
ment for stroke-survivors was to be implemented.
Clinician facilitators suggest benefits in either primary 
or secondary care settings, but also in a collaborative 
model of care between the two. This latter finding echoes 
recommendations from the UK Intercollegiate Stroke 
Working Party for a collaborative care model, linking 
community and specialist care, with the aim of integrated 
long-term follow-up for those presenting neuropsycho-
logical problems.17 Although both primary and secondary 
care clinicians could see the benefits of carrying this assess-
ment in their own specialties, some of the patients and 
carers in this study valued their relationship with their GP. 
Further, primary care clinicians themselves are familiar 
with the process of risk assessment. A survey of primary 
care physician trainees found that they were also keen to 
implement a dementia risk assessment strategy to assist in 
earlier identification.25 However, potential barriers have 
been identified in previous studies, such as system-related 
factors (lack of support, time constraints)26 27 and training 
in dementia,27 which would need to be addressed. Risk 
assessment is an objective process requiring specific indi-
vidual variables for example, age, gender and education. 
Such data is readily available in primary care in many 
countries where electronic medical record systems are 
in place. Further, GPs are already asked to assess cardio-
vascular risk as part of routine clinical care.28 However, 
some GPs themselves do not like using risk assessment 
tools particularly as the tools do not provide the support 
needed in communication.29 Training in communicating 
the risk assessment process, particularly in the context 
of dementia, would be required if this were to be imple-
mented in clinical practice. Further, some models, partic-
ularly those developed in stroke populations11 may also 
include variables such as complex imaging data, which 
will only be available in secondary care and may be diffi-
cult to obtain even in specialist settings. If risk assess-
ment were to be conducted in primary care, then the risk 
assessment models utilising data which can be accessed in 
primary care, needs to be externally validated in stroke 
populations to assess their accuracy.
Clinician participants were concerned about whether 
risk assessment would actually change standard prac-
tice. In a stroke population, it is unclear whether iden-
tifying those at risk would achieve any additional benefit 
from a risk factor modification point of view. This is 
because stroke-survivors already receive annual commu-
nity follow-up with particular focus on vascular risk 
factor modification. However, current evidence suggests 
that development of post-stroke dementia is more than 
just about vascular risk and would require a different 
approach for example, psychological support, cognitive 
preservation strategies and additional resources. Results 
from several trials, assessing whether vascular-based inter-
ventions can reduce dementia risk, have been largely 
disappointing.30 31 These results suggest that perhaps 
an individual’s risk of post-stroke cognitive impairment 
and dementia includes risk factors beyond vascular risk. 
Inflammation following a stroke seems to have both posi-
tive and negative effects and whether lowering inflam-
mation can prevent post-stroke dementia will need to be 
addressed in future trials.32
Currently population screening for dementia is not 
recommended due to a lack of evidence evaluating risks 
and benefits,33 despite positive views from older adults.34 
Risk assessment can target high-risk groups rather than 
the general population. Recent evidence has found a 
decline in age-specific incidence of dementia, particularly 
in high-income countries, suggesting that rising levels of 
education and modifying cardiovascular risk may have 
driven a decline in dementia risk.35 36 Indeed, the impor-
tance of modifiable risk factor reduction for dementia 
was reported in the World Alzheimer Report (2014)37 
and around a third of Alzheimer’s disease cases world-
wide might be attributable to modifiable risk factors.38 
Risk assessment tools use these modifiable risk factors to 
predict risk. Similar to other branches of medicine where 
risk assessment is used to predict risk of a future illness, 
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it would be hoped that this approach could reduce one’s 
risk of future dementia. Stroke affects more than 100 000 
people in the UK per year,39 creating a large population 
with cognitive deficits and/or at high risk of future decline 
who may benefit from risk assessment for dementia. 
However, participant groups in this study, particularly 
clinicians, reported that given the potential ramifications 
of risk assessment, individuals should be given the choice 
of whether to undergo assessment. Some stroke-survivors 
were positive about such an approach, but agreed that it 
should be up to the individual and the family rather than 
applied universally. Participants in this study recognised 
the anxiety this process could generate particularly when 
the perceived possible interventions for dementia are 
limited. The National Institute for Health and Care Excel-
lence have recently updated their guidance and have 
concluded that case finding should only be conducted as 
part of a clinical trial, which also provides an interven-
tion.40 Therefore, careful discussion needs to be adopted 
with the the patient and their carers before undertaking 
such a process in any setting. In the context of the 
dementia diagnostic journey, transition from living with 
an undiagnosed memory problem to being diagnosed 
with a dementia illness is underpinned by uncertainty.41 
Although risk assessment certainly does not provide any 
certainty for a dementia illness, the discussions and objec-
tive evaluation using the tools may help the individuals 
process their current condition and assist in the prepa-
ration for a potential diagnosis of dementia. Preparation 
was mentioned by participants in this study as a facilitator 
for risk assessment.
Clinical implications
Case finding for dementia involves actively assessing 
individuals at risk of a future dementia illness, which at 
present is only recommended in clinical trial settings 
due to a lack of post-assessment intervention.42 Once a 
suitable intervention is found however, the views of those 
conducting the assessment and the recipients of such an 
assessment will need to be assessed. Similarly there will be 
challenges with regards to assessment of capacity when 
performing risk assessment for this at-risk population. It 
is also important to note that GPs find communicating 
the diagnosis of dementia difficult.43 Although risk assess-
ment is not providing a diagnosis of dementia, careful 
consideration will be required in training health profes-
sionals in communicating the concept of risk for a disease 
such as dementia. From this study we have identified the 
priorities according to each stakeholder group which 
would need to be addressed prior to clinical implemen-
tation in the future.
limitations
The participants in this study came from one area of 
England and were Caucasian. The patient participants 
were also well enough to attend outpatient assessment 
clinics. Future studies could look to explore views in other 
populations including views from minority ethnic groups, 
the patients with more severe stroke-related impair-
ments and different service models. Due to familiarity, 
it is recognised that clinicians expanded more around 
the risk assessment process. Despite this being the case, 
the patients and carers were given the opportunity to 
understand the concept of risk assessment as part of the 
interview process, but the emphasis on a need for a diag-
nosis and good care was what was important for them. 
Participants were also aware that the interviewer was also 
a primary care clinician, which may have the potential to 
introduce bias into participant responses. This is because 
a clinician interviewer may be viewed as an expert and 
judge in clinical decision making and moral judgements 
made.44 On the other hand interviews tend to be broader 
in scope and richer in data when conducted by a clini-
cian researcher.44 Further, both clinical and non-clinical 
members contributed to the analysis of the data to mini-
mise the effect this may have had.
COnClusIOns AnD future reseArCh
Timely recognition of those at risk of dementia is crucial 
to enable individuals early access treatment and support. 
Although dementia screening after stroke is not yet advo-
cated on preventative grounds, assessing risk has some 
potential benefits for individuals who make an informed 
choice to participate. There would need to be better 
cohesiveness of communication between primary and 
secondary care, with more support placed in the commu-
nity. Further, it should be recognised that if risk assess-
ment were to be incorporated into clinical practice, this 
will potentially place additional burdens on a dementia 
diagnostic service, which is already overstretched. Next 
steps are to identify which tool to use, how best to manage 
those who are deemed high-risk individuals and whether 
there are any interventions, which can reduce their risk. 
Future studies will need to look specifically at what factors 
put a stroke-survivor at risk that could be potentially 
modified and also whether there are specific interven-
tions suitable to a post-stroke population to reduce risk.
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